Navamedic
1 investor is following this company
Navamedic is a Nordic pharma company and supplier of products in consumer health, medical nutrition for rare diseases, specialty pharma, and branded generics covering therapeutic areas such as obesity, women’s health, urology, and gastro. The products are distributed to hospitals and pharmacies. Navamedic is present in all Nordic countries, Benelux and Baltics, and sales in the UK and Greece. Navamedic is headquartered in Oslo, Norway, and was founded in 1999.
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
Oslo Børs
NAVA
Daily low / high price
-
Market cap
-
Turnover
-
Volume
-
Financial calendar
Interim report
16.08.2024
Interim report
31.10.2024
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Ingerø Reiten Inv. Company | 20.5 % | 20.5 % |
UBS Switzerland | 11.4 % | 11.4 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Navamedic ASA - Mandatory notification of trade
NAVA: Navamedic and Orion Corporation sign License & Supply Agreement for Flexilev® in Europe
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools